|
Combinations
|
xylS
|
Pm
|
5'-UTR
|
Induced*
|
Uninduced*
|
Reference
|
|---|
|
wild-type
|
wild-type
|
wild-type
|
wild-type
|
0.2 - 0.4
|
0.005 - 0.01
|
This study
|
|
comP
|
wild-type
|
ML2-5
|
wild-type
|
1 – 2
|
0.005 - 0.01
|
[15]
|
|
comU
|
wild-type
|
wild-type
|
H39
|
2 – 3
|
0.06 - 0.08
|
This study
|
|
comX
|
StEP-13
|
wild-type
|
wild-type
|
1 – 2
|
0.02 - 0.03
|
[17]
|
|
comPU
|
wild-type
|
ML2-5
|
H39
|
5 – 6
|
1 - 1.5
|
This study
|
|
comXP
|
StEP-13
|
ML2-5
|
wild-type
|
3 – 4
|
0.3 - 0.4
|
This study
|
|
comXU
|
StEP-13
|
wild-type
|
H39
|
12 – 13
|
0.8 - 0.9
|
This study
|
|
comXPU
|
StEP-13
|
ML2-5
|
H39
|
15 – 20
|
3 - 4
|
This study
|
- * Phenotypes are given as ampicillin resistance levels (mg mL-1) under induced (0.1 mM m-toluate) and uninduced conditions.
